immunoassay

AEON Technologies, now known to the public as AEON Labs, is a full-service clinical laboratory serving Maryland, Pennsylvania, and West Virginia. Launched in 2020 during the early days of the pandemic to provide SARS-CoV-2 diagnostics, it now offers nearly 200 different diagnostics from a 3,000 square foot laboratory in Frostburg, MD, with a sample processing capacity of 2,000 samples per day.

assay development and validationclinical chemistryclinical trial managementcoagulationhematologyinfectious disease testingonsite sample processingpharmacogenomics (PGx)phlebotomytoxicology

ALPCO (American Laboratory Products Company) is a global developer and provider of molecular and immunodiagnostic products focused on infectious and gastroenterological diseases. Founded in 1991 as an importer and distributor of immunoassay-based products, it is a producer of immunodiagnostic reagents for specialty testing laboratories. In April 2022 it merged with GeneProof, a molecular diagnostics company offering real-time PCR kits and automated instrument platforms.

immunodiagnosticsmolecular diagnosticsnucleic acid extractionReal-time PCRsample-to-answer testing

Arbor Assays is a proudly employee-owned company based in Ann Arbor, Michigan, dedicated to delivering high-quality detection and immunoassay kits. On January 1, 2017, it became the world's first employee-owned life sciences company through a perpetual employee benefit trust (EBT). It builds high-quality detection and immunoassay kits known for sensitivity, speed, and convenience, using top-tier suppliers and referencing WHO or NIST standards.

chemiluminescent ELISAcolorimetric detectionELISAsample testing services

Axis Forensic Toxicology is a forensic toxicology laboratory that provides accurate, timely and relevant toxicology results through testing protocols, cost-effective products and access to subject matter experts. It serves coroners, medical examiners, and law enforcement, specializing in postmortem, drug-facilitated crime, and meconium-based tests, and also serves as a reference lab providing expertise and verification. The company has led the field in designer drug testing and research for over 25 years.

designer drug testing and researchdrug-facilitated crime testingexpert witness testimonyextractionforensic toxicology testingGC/MSHPLCliquid chromatography-mass spectrometry (LCMS)meconium-based testingmethod development and validationnew psychoactive substances (NPS) analysispostmortem toxicologyreference laboratory services

Baebies is a diagnostics company headquartered in Research Triangle Park, North Carolina, with a satellite facility in Hyderabad, India. Founded by Vamsee Pamula and Richard West, it develops the FINDER multifunctional diagnostic platform powered by proprietary digital microfluidics technology, integrating molecular, immunoassay, chemistry, and coagulation testing on a single compact system for near-patient use.

assay developmentchemistry testingcoagulation testingdigital microfluidicsmolecular testingnear-patient diagnostics

BioPhysics Assay Laboratory (BioPAL), Inc. is a privately held, for-profit company based in Worcester, Massachusetts. It develops and sells novel tools for the life science and biomedical communities, and was the first company to commercialize non-radioactive products using neutron activation technology as the read-out system. BioPAL also develops and sells nanoparticles for MRI, magnetic separation applications, and time-resolved fluorescent technology.

alkaline phosphatase conjugationsconjugation to iron colloidscustom conjugationsfluorescent tagginggadolinium labelingGFR assay labHRP conjugationsMRI cell labeling and trackingneutron activation analysis

Bio-Rad is a global leader in developing and manufacturing a wide range of products for the life science research and clinical diagnostic markets. The company provides instruments, reagents, quality control solutions, and data tools for research, manufacturing, testing, and education, spanning applications from PCR and chromatography to clinical diagnostics and food safety testing.

chromatographyDroplet Digital PCRFlow Cytometrymanufacturingmolecular diagnosticsmonoclonal antibody generationPCR

EnquBio Inc is a San Diego-based drug R&D technology and service company (preclinical CRO) that advances pharmaceutical and biotechnology research through a comprehensive suite of drug discovery solutions. Located in San Diego's biotech hub, it operates state-of-the-art facilities led by an industry-recognized team, offering expertise in exploratory biology, high-throughput screening, SAR studies, in vitro and in vivo pharmacology, immunology-focused studies, biomarker discovery, and clinical sample analysis.

assay developmentbioanalysisbiomarker discoverycell line generationex vivo pharmacologygene expression analysisgenome editinghigh-content screeninghigh throughput screeningimmunophenotypingin vivo imagingin vivo pharmacologyiPSC platformnon-GLP toxicologyPK/PD analysisWestern blot

Eve Technologies is a bioanalytical contract research organization (CRO) providing multiplex assay services for biomedical and life science researchers and pharmaceutical companies. It offers Discovery Assays and Custom Plex Assays for protein analysis and drug discovery, delivering reproducible, quantitative immunoassay data from small sample volumes. Its clinical diagnostics division, Eve Diagnostics, is a CLIA-certified laboratory offering Laboratory Developed Tests in General Immunology.

biomarker profilingCLIA-certified high-complexity clinical testingcytokine quantificationmultiplex assay platforms (Bio-Plex Suspension Array System, Milliplex, Luminex, Meso Scale Discovery)protein analysis

Rhythm Biosciences (ASX:RHY) is a medical diagnostics technology company transforming cancer diagnostics through innovative technologies that predict, detect, characterise, and support early intervention. Its flagship blood-based technology ColoSTAT® is a blood-based test for the detection of colorectal cancer in symptomatic patients, and the geneType™ platform is a personalised predictive test portfolio combining genomic and clinical information to predict risk of chronic disease development.

blood-based diagnosticscancer diagnosticsgenomic and clinical risk assessment